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Abstract
Polyphenols as ‘‘sensitizers’’ together with cytotoxic drugs as ‘‘inducers’’ cooperate to trigger apoptosis in various cancer
cells. Hence, their combination having similar mode of mechanism may be a novel approach to enhance the efficacy of
inducers. Additionally, this will also enable to achieve the physiological concentrations facilitating significant increase in the
activity at concentrations which the compound can individually provide. Here we propose that polyphenols (Resveratrol
(RES) and Curcumin (CUR)) pre-treatment may sensitize MCF-7/MDA MB-231 (Human Breast Cancer Cells, HBCCs) to
Centchroman (CC, antineoplastic agent). 6 h pre-treated cells with 10 mM RES/CUR and 100 mM RES/30 mM CUR doses,
followed by 10 mM CC for 18 h were investigated for Ser-167 ER-phosphorylation, cell cycle arrest, redox homeostasis, stress
activated protein kinase (SAPKs: JNK and p38 MAPK) pathways and downstream apoptosis effectors. Low dose RES/CUR
enhances the CC action through ROS mediated JNK/p38 as well as mitochondrial pathway in MCF-7 cells. However, RES/CUR
sensitization enhanced apoptosis in p53 mutant MDA MB-231 cells without/with involvement of ROS mediated JNK/p38
adjunct to Caspase-9. Contrarily, through high dose sensitization in CC treated cells, the parameters remained unaltered as
in polyphenols alone. We conclude that differential sensitization of HBCCs with low dose polyphenol augments apoptotic
efficacy of CC. This may offer a novel approach to achieve enhanced action of CC with concomitant reduction of side effects
enabling improved management of hormone-dependent breast cancer.
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Introduction
Anti-estrogen therapies constitute the mainstay of current
treatment for breast cancer [1]. Centchroman (CC), a tripheny-
lethylene Selective Estrogen Receptor Modulator (SERM) has
been considered a potential anti-breast cancer drug in ER-positive
(MCF-7)/2negative (MDA MB-231) Human Breast Cancer Cells
(HBCCs) as well as with all stages of hormone-responsive breast
cancer [2–4]. Studies have demonstrated that low concentrations
of triphenylethylenes in patients cause modest, partial estrogen-like
action [5]. Although once a steady level is achieved the drug shows
its anti-estrogenic properties whose attainment requires 4–8 weeks
[5]. Therefore, to overcome the low dose estrogenic effects of
triphenylethylenes, one alternative approach would be to sensitize
the cells through supplementing compounds (polyphenols) having
similar mode of action. This in turn enables achievement of
physiological levels facilitating significant increase in the activity at
concentrations which the compound can individually provide. For
this reason, polyphenols like Resveratrol (RES) abundant in wine
and Curcumin longa derived Curcumin (CUR) a South Asian and
Middle Eastern spice were selected as Type I estrogens similar to
CC for preconditioning the cells [5]. Moreover, 2–3 times higher
retention of polyphenols in local tissue as compared to the plasma
levels [nM to low mM( ,2 mM ); retention time ,5–6 h] [6,7]
may positively influence the cell susceptibility to triphenylethy-
lenes.
Therefore, we pre-treated estrogen-deprived CC treated
MCF-7/MDA MB-231 cells with physiological and pharmaco-
logical doses of polyphenols to synergize or antagonize the drug
action. Both, polyphenols (CUR and RES) and CC bind to
ERa and b with lower affinity than E2 [8,9] involving ER-
dependent and -independent pathways [2,10–13]. Hence,
sensitization with low dose polyphenols may modulate the
receptor levels/redox status overtly improving CC efficacy.
Contrarily, high dose polyphenols may disrupt ER and enhance
the ER-independent antiproliferative effect in the combination.
This may modulate proapoptotic (Bax, Caspase-9), versus
antiapoptotic genes (Bcl-2) ratio and transcription factors p53,
including c-Jun and phospho-ATF-2 to play a crucial role in
sensitizing the caspase-3 deleted and p53 mutant MCF-7 and
MDA MB-231 respectively.
Hence, we investigated the mode of action of polyphenol-
sensitized, CC treated MCF-7/MDA MB-231 cells on cell cycle,
redox homeostasis, stress activated protein kinase (SAPKs: JNK
and p38 MAPK) and downstream apoptosis effectors. We also
employed a series of inhibitors for p53, JNK and p38 pathways
critical for time-dependent cytotoxicity of CC and polyphenols.
Both RES and CUR at physiological dose potentially sensitize
CC-induced apoptosis in MCF-7 cells through modulating the
above factors. Pharmacological sensitization significantly arrests
the cells (Go/G1 phase; RES and G2/M phase; CUR) rescuing
them from CC-induced apoptosis through unaltered factors to
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with low dose RES (JNK/p38-independent)/CUR (JNK/p38-
dependent), the apoptosis enhanced in CC treated MDA MB-
231 cells. Contrarily, with high dose polyphenol sensitization
CC in both the combinations showed JNK/p38-dependent
apoptosis. This therefore reinforces our hypothesis about the
usage of polyphenols to ameliorate Estrogen-dependent/inde-
pendent breast cancer with enormous translational potential
during combination chemotherapy employing Centchroman.
Materials and Methods
Materials
Dulbecco’s Modified Eagle’s Medium (DMEM) with or without
phenol red, N-[2-Hydroxyethyl] piperazine-N9-2-ethanesulfonic
acid (HEPES), Penicillin G, Streptomycin sulfate, Gentamicin
sulfate, Dulbecco’s Phosphate Buffered Saline (PBS), Propidium
Iodide (PI), Ribonuclease-A, inhibitors specific to JNK
(SP600125), p38 (SB203580) and pifithrin (Pif) were purchased
from Sigma Chemical Co., St. Louis, MO, USA. 29,7 9-
Dichlorofluorescin Diacetate (DCFDA) from Merck–Calbiochem
whereas Fetal Calf Serum (FCS) was procured from GIBCO BRL
Laboratories, New York, USA. 5,59,6,69-tetrachloro-1,19,3,39-
tetraethyl-benzimidazolylcarbocyanine Chloride (JC-1) was pur-
chased from BioVision Research Products (Mountain View, CA,
SA). Protease and Phosphatase inhibitor cocktails, Cell Lysis M
TM
Cell Lysis reagent, antibodies against b-actin, p53, phospho (Ser-
15) p53, MnSOD, Catalase, non-activated p38, phosphor Ser-167
AF-1 region of ERa and ExtrAvidinH Alkaline Phosphatase
Staining kit as well as BCIP/NBT tablets were from Sigma
Chemical Co. (St. Louis, MO, USA). Antibodies against Bcl-2,
Bax, JNK 1/2 were purchased from BioVision Research Products
(Mountain View, CA, SA). p38 MAPK Kinase Assay Kit was from
Cell Signalling whereas Kinase Star
TM JNK Activity Assay Kit
was procured from Biovision. All other chemicals used were of
analytical grade.
Cell Culture
MCF-7/MDA MB-231 (Human Breast Cancer, epithelial) cells
were procured from the National Center for Cell Sciences
(NCCS), Pune, India. These cells were routinely cultured as
reported previously by us [14,15]. Briefly, the cells were cultured
in DMEM pH 7.4, containing Penicillin (200 mg/mL), Strepto-
mycin (100 mg/mL), Gentamicin (60 mg/mL) supplemented with
10% FCS and 10 mM HEPES in a humidified 5% CO2 incubator
at 37uC.
Treatments
For experimental purpose, the cells from a 70–80% confluent
flask were trypsinized and cultured for a total of 3 days. Initially for
the first 2 days, the cells were conditioned in phenol red-free
DMEM containing Penicillin (200 mg/mL ), Streptomycin
(100 mg/mL), Gentamicin (60 mg/mL), L-Glutamine (2 mM), D-
Glucose(1 g/L), Sodium pyruvate (0.11 g/L), HEPES (10 mM)
supplemented with 10% Dextran Coated Charcoal stripped FCS
(DCC/FCS) (2). Subsequently, the cells were pre-treated with
polyphenols (RES: 10/100 mM and CUR: 10/30 mM) for 6 h and
continued with CC (10 mM) for next 18 h (total of 24 h).
Polyphenols, SP600125 and SB203580 were dissolved in dimethyl
sulphoxide (DMSO). Controls were treated with 0.1% DMSO.
The cell number used for each experiment has been described
individually.
Inhibitor Treatments
ROS inhibition was performed using N-Acetyl-l-Cysteine (L-
NAC, 5 mM) 1 h prior to treatment with drugs. For JNK/p38
pathway inhibition, during the 6 h exposure to polyphenols (RES:
10/100 mM and CUR: 10/30 mM), JNK inhibitor (10 mM
SP600125)/p38 pathway inhibitor (1 mM SB203580)/p53 path-
way inhibitor (15 mM Pif) was added during the last two hours
prior to CC exposure. The last regimen with CC was continued
until 18 h. The cells were analyzed by FACS (PI 40 mg/mL),
western blotting and immunoprecipitation. These concentrations
of inhibitors (L-NAC, SP6000125, SB203580 and Pif) were
nontoxic to cells under our pre-incubation conditions (data not
shown).
Cellular Morphological and Cell-Cycle Analysis
For time-dependent morphological analysis, 0.2610
6cells were
seeded in a 6-welled plate and treated for 3, 6 or 24 h with
polyphenols (RES: 10/100 mM and CUR: 10/30 mM) or pre-
conditioned with polyphenols for 6 h and continued with CC
(10 mM) for next 18 h. These cells were then photographed by
a Nikon Eclipse Ti inverted phase contrast microscope. Cells were
also stained with 40 mg/mL PI prior to analysis by a FACS calibur
instrument (Becton Dickinson, San Jose, CA, USA) employing the
Cell Quest Software [15].
Modulation of Mitochondrial Membrane Potential (Dym)
and Intracellular Reactive Oxygen Species (ROS)
Generation
Mitochondrial Membrane Potential (Dym) was measured by
the uptake of JC-1 which is a dye that stains mitochondria in living
cells in a membrane potential dependent fashion. In apoptotic cell,
the dye stays in the cytoplasm as a monomer and fluoresces green
(527 nm), while in healthy cells, the dye aggregates in the
mitochondria and fluoresces red (590 nm). For the experiment,
0.2610
6 cells were plated in a 6-welled plate, treated as above,
washed and finally harvested in chilled PBS containing 1 mM JC-
1. The samples were incubated at 37uC for 30 min in dark,
washed twice with PBS and fluorescence intensities were de-
termined on a Flow Cytometer [15].
Cells were seeded at a concentration of 10610
3 cells per well in
black 96-well plates. Cells were treated time-dependently with
polyphenols or pre-conditioned with polyphenols for 6 h and
continued with CC (10 mM) for next 18 h (total of 24 h). This was
followed by incubation with 10 mM2 9,79-dichlorofluorescin
diacetate (DCFDA) (Molecular Probes, Eugene, OR) for 30 min.
Cells were then rinsed with PBS and then placed in a pre-warmed
37uC fluorimeter for time-dependent measurement (DCFDA Ex
480 nm, Em 530 nm). Following this, the supernatant was
removed and a protein assay was performed on the cells. The
final results have been corrected for variations in the protein
concentration between wells and are expressed as a percentage
activity in untreated controls being 100%. Flow cytometry analysis
of cells stained with DCFDA was performed to confirm results
using 5 mM L-NAC. HBCCs were plated in 6-well plates and
treated time-dependently with polyphenols or pre-treated with
polyphenols accompanied in the presence of DCFDA (10 mM).
Fluorescence was measured with a Flow Cytometer (Ex 500 nm,
Em 530 nm) [15].
Determination of Total Glutathione (GSH)
Quantification of total GSH was accomplished using a Gluta-
thione Assay Kit from Sigma. According to the manufacturer’s
instructions, 1610
8 cells were exposed as above and deproteinized
Polyphenols Sensitize HBCCs for Centchroman
PLoS ONE | www.plosone.org 2 June 2012 | Volume 7 | Issue 6 | e37736with 5% 5-Sulfosalicylic Acid solution after three rounds of
alternate freeze-thawing, centrifuged to remove the precipitated
protein and the supernatants assayed for GSH. The kit uses
a kinetic assay in which catalytic amounts (nM) of GSH cause
a continuous reduction of 0.031 mg/mL DTNB (5,59-dithiobis (2-
nitrobenzoic acid) to TNB (monitored at 412 nm in a SpectraMax
M2 Multiwell Plate Reader). The GSSG formed is reduced by
glutathione reductase (0.115 units/mL) and 48 mM NADPH to
additionally give a positive value. The amount of GSH was
calculated from a standard curve generated under similar
conditions.
Superoxide Dismutase and Catalase Activities
Superoxide dismutase (SOD) and Catalase (CAT) activities were
determined according to McCord and Fridovich, and Beutler
[16,17] respectively. Untreated as well as treated 3610
6 MCF-7/
MDA MB-231 cells were collected by scraping, centrifuging and
the pellets sonicated in chilled 1.15% KCl. The cell extract was
spun at 15006g for 5 min at 4uC. The resulting supernatants were
analyzed for enzyme activities. The specific activity of SOD was
calculated as follows: Specific Activity = A6dilution fac-
tor61000/One unit6volume of enzyme (ml)6mg protein.
‘‘A’’=OD change/min of controlled reaction-OD change/min
of experiment, ‘‘One unit’’=(OD change/min of controlled
reaction)/2. Here, one unit means 50% reduction in NBT
reduction as compared to control. The specific activity of CAT
was calculated by the following equation: Specific Activity = OD
change/min6dilution factor61000/0.003946volume of enzyme
(ml)6mg protein = mmol H2O2 reduced/min/mg protein. Each
data point was performed in triplicate and the results reported as
Mean Absorption 6 SD.
Western Blotting
3610
6 cells were cultured in T-75 flasks and treated as above.
Pellet was disrupted in lysis buffer procured from Cell Lysis M
TM
Cell Lysis reagent, Sigma Chemical Co. (St. Louis, MO, USA)
supplemented with protease and phosphatase inhibitor cocktail as
per manufacturer’s protocol. The supernatant was assayed for
protein content [18]. 50 mg of protein per lane were processed for
western blotting by SDS-PAGE and electro-transferred to
nitrocellulose membranes. Membranes were probed with the
appropriate primary antibodies against MnSOD, Catalase, Total
p53, phospho p53 (Ser-15), JNK 1/2, non-activated p38, Bcl-2,
Bax, active Caspase-9 and Ser-167 phosphorylation of AF-1
region of ERa. All primary antibodies were used at recommended
dilution in 1% bovine serum albumin in Tris buffered saline with
0.1% Tween
TM 20. Reactions were visualized with biotin
conjugated secondary antibody and subsequently with avidin
linked Alkaline-Phosphatase enzyme conjugate according to the
manufacturer’s protocol. Immuno-detection was accomplished
using insoluble colored substrate BCIP/NBT.
Assay for JNK and p38 Activity
KinaseStar
TM JNK Activity Assay Kit (BioVision) was used to
assess JNK activity according to the manufacturer’s instructions.
Briefly, activated JNK was immunoprecipitated by incubating
cell lysates for 45 min with an immobilized JNK specific
antibody at room temp. The in vitro kinase assay was then
performed using c-Jun protein/ATP mixture as substrate. Levels
of phosphorylated c-Jun were then detected by western blotting
using an anti phospho-c-Jun (Ser 73) antibody.
p38 activity was assessed using a non-radioactive p38 MAP
Kinase Assay Kit (Cell Signalling) according to the manufacturer’s
instructions. Briefly, phosphorylated p38 was immunoprecipitated
by incubating cell lysates overnight with an immobilized phospho-
p38 antibody at 4uC. An in vitro kinase assay was then performed
using an ATF-2 fusion protein as substrate. Levels of phosphor-
ylated ATF-2 were then detected by western blotting using
a phospho-ATF-2 (Thr71) antibody.
Statistical Analysis
The results are expressed as Mean 6 SD from one of three
similar experiments each performed in triplicate. Student’s ‘t-test’
was used to determine the level of significance and the following
values assigned * P,0.05; y P,0.01; # P,0.001, calculated
compared to control unless stated otherwise.
Results
Morphological and Cell-Cycle Changes in Polyphenols
per se and Polyphenols Sensitized CC Treated MCF-7/
MDA MB-231 Cells
Time-dependent, cytomorphological analysis shows typical
epithelial morphology at low doses of polyphenol treated MCF-
7/MDA MB-231 cells as compared to control at all time points.
Adversity begins in high doses of polyphenols as early as 6 h and
reaches to its maximum at 24 h in MCF-7 (Fig. 1A). While in
MDA MB-231 cells, 30 mM CUR displays changes as early as 6 h
until 24 h. However, 100 mM RES displays changes only at 24 h
(Fig. 1B). CC alone time-dependently deteriorates the morphol-
ogy, evident by decrease in cell density in MCF-7 cells which was
restricted to 24 h time point in the other cell type (Fig. 1A and B).
At 24 h, low dose polyphenol sensitizes CC treated cells
showing higher degree of distortion compared to either drug
alone. On sensitizing with high doses of polyphenols, CC depicts
adverse morphology as compared to CC and polyphenols alone in
both the cells (Fig. 1A and B).
To determine whether polyphenols pre-treatment augments
apoptosis in CC treated MCF-7/MDA MB-231 cells, a sub-G0/
G1 DNA peak, suggestive of apoptotic DNA was tested. However,
the number of cells in this population on treatment with 10 mM
RES increased significantly with 6 h which extended up to 24 h.
Even though the cells were undergoing apoptosis, they passed
from G1 to S and G2 phase. The transition of cells from S to G2/
M phase was blocked within 6 h and the inhibition persisted up to
24 h, the time point at which most of the cells were arrested in S
phase. With higher dose of RES, the cells were arrested in G0/G1
phase as early as 3 h and continued up till 24 h. This goes on
along with unaltered S phase and time-dependent decrease in G2/
M phase (Fig. 2A). In MDA MB -231 cells, 10 mM RES showed
increased cell death by 24 h accompanied with decreased G2/M
phase. However, it failed to evoke any S-phase arrest compared to
MCF-7 cells. Conversely, 100 mM RES showed equivalent sub-
G0/G1 compared to 10 mM RES, significant accumulation of
G0/G1 and decline in G2/M cells, initiated at 3 h and continued
up till 24 h (Fig. 2B).
CC when added to the culture separately, the transition of
cells from G1 to S phase was blocked within 3 h but with longer
treatment, the inhibition was released and the cells started
cycling again accompanied with apoptosis in MCF-7 cells. Time-
dependent increase in sub-G0/G1 cells was observed in MDA
MB-231 cells (Fig. 2C). The cell number in sub-G0/G1
population increased with time up to 24 h with 10 mM CUR
treatment with concomitant decrease in G0/G1 population in
MCF-7 cells (Fig. 2D), while remaining unaltered G0/G1 in
MDA MB-231 cells (Fig. 2E). With 30 mM CUR, the cells
undergoing apoptosis passed from G1 to S and G2/M phases
Polyphenols Sensitize HBCCs for Centchroman
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PLoS ONE | www.plosone.org 4 June 2012 | Volume 7 | Issue 6 | e37736Figure 1. Time-dependent morphological analysis. 0.2610
6cells were seeded in a 6-welled plate and treated for 3, 6 and 24 h with
polyphenols (RES: 10/100 mM and CUR: 10/30 mM) and CC (10 mM) alone or preconditioned with low/high dose polyphenols for 6 h and continued
with CC (10 mM) for next 18 h {A (MCF-7) and B (MDA MB-231)}. The cells were then photographed by a Nikon Eclipse Ti inverted phase contrast
microscope. Data shown is one of the three similar experiments each performed in triplicate.
doi:10.1371/journal.pone.0037736.g001
Figure 2. Cell-Cycle analysis of RES, CUR and CC treated MCF-7 cells (Time-dependent and sensitized). Briefly, 0.2610
6 cells were pre-
cultured for 48 h in phenol red-free DMEM then exposed for 3, 6 and 24 h with 10 mM/100 mM RES {A (MCF-7), B (MDA MB-231)}, 10 mM CC (C),
10 mM/30 mM CUR {D (MCF-7), E (MDA MB-231)} or preconditioned cells with polyphenols (RES: 10/100 mM and CUR: 10/30 mM) for 6 h and continued
with CC (10 mM) for next 18 h (total of 24 h). Following incubations the MCF-7 (F) and MDA MB-231 (G) cells were harvested, permeabilized, stained
with Propidium Iodide (40 mg/mL) and analyzed by Flow Cytometer (employing Modfit Software); % CV ,10. Data shown are the mean 6 S.E. of one
of the three similar experiments each performed in triplicate. * P,0.05; ** P,0.01; *** P,0.001, calculated compared to control. $ P,0.05; $$ P,0.01;
$$$ P,0.001 with respect to individual CC dose and # P,0.05; ## P,0.01; ### P,0.001 with respect to individual RES dose.
doi:10.1371/journal.pone.0037736.g002
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MDA MB-231 cells (Fig. 2D and E).
MCF-7 cells pre-treatment with 10 mM RES for 6 h, CC
significantly up-regulates sub-G0/G1 peak, S phase arrest and
down-regulates G0/G1, G2/M phase than either drug alone
(Fig. 2F). For MDA MB-231 cells under similar conditions, higher
sub-G0/G1 and decreased G2/M was observed (Fig. 2G). In
100 mM RES sensitized CC treated cells G0/G1, S and G2/M
phases mirrored with 100 mM RES apart from significant decline
in sub-G0/G1 population in MCF-7 cells and unaltered in MDA
MB-231 cells (Fig. 2F and G). Upon comparing with CC alone,
the G0/G1 arrest improved whereas sub-G0/G1, G2/M phases
showed remarkable decline in MCF-7 cells and remain unchanged
for MDA MB-231 cells (Fig. 2F and G). With 10 mM CUR
sensitization, CC significantly augments sub-G0/G1 peak leaving
the rest unaltered as compared to individual drugs per se in MCF-7
(Fig. 2F). Interestingly, 10 mM CUR sensitized CC treated MDA
MB-231 cells displayed G2/M phase arrest with enhanced sub-
G0/G1 peak as compared to drugs alone (Fig. 2G). In 30 mM
CUR sensitized CC treated MCF-7 cells, major decline in sub-
G0/G1 phase vis-a `-vis CUR alone was observed whereas reverse
was true for MDA MB-231 cells. On the other hand, G0/G1 and
G2/M under similar situations remain unaltered. On comparison
with CC, G0/G1 population decreases whereas G2/M phase
shows remarkable up-regulation in MCF-7 cells. Significant
increase in sub-G0/G1 peak was observed in MDA MB-231 cells
(Fig. 2F and G).
Disruption of Mitochondrial Membrane Potential (DYm)
and Reactive Oxygen Species Generation in Polyphenol
per se and Polyphenol Sensitized CC Treated MCF-7/MDA
MB-231 Cells
ROS generation studies were performed through DCFDA-
uorimetric analyses. Low dose polyphenols cause significant
increase in ROS at 24 h. This is in agreement with corresponding
changes in DYm only at 24 h in MCF-7 cells. Progressive increase
in dose-dependent RES-induced ROS generation from 3–24 h
was noticed for MDA MB-231 cells with significance only at 24 h
accompanied with concomitant disruption of DYma t2 4 h .
However, dose-dependent CUR in MDA MB-231 cells acted
differently inducing ROS and disruption of DYm from 6 through
24 h (Fig. 3A and B). Unlike the low dose polyphenols in MCF-7
cells, 100 mM RES induces ROS at 3 h, with significant reduction
at 24 h. Vis-a `-vis, 30 mM CUR shows drastic generation of ROS
as early as 3 h sustained until 24 h (Fig. 3A). The polyphenols
associated dichotomy in cell-cycle owes itself to ROS generation
significantly pronounced at the higher dose is a unique observa-
tion. As ROS generation is cell-cycle dependent phenomenon
[19,20], RES (100 mM) arrests the cells in G0/G1 phase (3 h)
resultantly letting the cells evade the remainder events of the cycle
accompanied with minimal ROS generation. Conversely, 30 mM
CUR at 3–24 h permits the transition of cells from G1 to S phase
to final arrest in G2/M phase owing to persistent ROS generation.
Time-dependent gradual decrease in 100 mM RES and persistent
ROS generation leads to disruption of DYm in MCF-7 cells [21]
(Fig. 3A and B).
However, low dose polyphenols sensitized CC treated cells
display increase in ROS and concomitant disruption of DYm than
CC alone both in MCF-7 and MDA MB-231 cells (Fig. 3C and
D). Conversely, decreased ROS was observed with 100 mM RES
sensitized CC treated cells vis-a `-vis the ligands per se in MCF-7 cells
remaining unaltered in MDA MB-231 (Fig. 3C). On addition of
CC to 30 mM CUR sensitized cells, ROS generation declined
versus CUR but significantly enhanced vis-a `-vis CC (Fig. 3C) in
both the cell types. The high dose polyphenol combination
severely disrupts DYm compared to CC alone in MCF-7 cells
only. As compared to high dose polyphenols alone, DYm
remained unaltered in both the cell types (Fig. 3D). Further,
cytometry reveals that 5 mM L-NAC, inhibits ROS generation by
low dose of polyphenols separately or with sensitized cells in MCF-
7 and MDA MB-231 cells (Fig. 3E). In MCF-7 cells, L-L-NAC
failed to respond with 100 mM RES either or in CC treated
whereas it inhibited 30 mM CUR without or with CC generated
ROS. Additionally, 100 mM RES/30 mM CUR alone or in CC
treated MDA MB-231 cells induced ROS, was also inhabitable by
L-L-NAC (Fig. 3E).
Differential Anti-oxidant Apparatus Expression in
Polyphenol Sensitized, CC Treated MCF-7/MDA MB-231
Cells
A sustained flux of ROS results in an imbalance of the
intracellular redox state regulated by Glutathione (GSH), Super-
oxide Dismutases (SOD) and Catalases (CAT) [22,23]. RES and
CUR both strongly inuenced total GSH dose-dependently where
the former down-regulated while the converse was true for the
latter in MCF-7 cells (Fig. 4A). However, in MDA MB-231 cells
total GSH remained unaltered through dose-dependent RES/
CUR (Fig. 4A). The disparity between the relative regulations of
GSH in MCF-7 cells may be attributed to structural dissimilarities,
extent of conjugation, half-life, stability etc. of the polyphenols in
question [24,25]. This coupled with the other sequel of events may
finally determine the fate of the cells. Sensitization with low dose
polyphenols in CC treated cells further reduced the total GSH
than with ligands alone in MCF-7 cells. Sensitization with 10 mM
RES in CC treated MDA MB-231 cells displays unaltered or
further reduced total GSH with RES and CUR respectively
compared to drugs alone. 100 mM RES sensitized CC treated cells
reduced the total GSH compared to CC alone in MCF-7.
However, this remains unaltered compared to RES alone in both
cell types (Fig. 4A). 30 mM CUR sensitized CC treated cells
reduced the total GSH compared to CUR to increase with CC
both in MCF-7 and MDA MB231 cells (Fig. 4A). Moreover,
compared to control unlike impervious MnSOD expression with
low dose polyphenols in both MCF-7/MDA MB-231 cells, the
SOD activity enhanced to decline at their respective higher dose.
However, in MDA MB-231 cells, polyphenols at both the doses
showed equivalent decline (Fig. 4B, 5 and 6). CC alone did not
alter the expression although the activity rose in MCF-7 and
decreased in MDA MB-231 cells. With 10 mM RES/CUR
sensitization, the level and activity has inverse relationship as
compared to CC alone in MCF-7 cells. With 10 mM RES/CUR
sensitization in CC treated MDA MB-231 cells, MnSOD level
remain unaltered while activity declined in both the cases
compared to CC per se. With high dose polyphenols sensitization,
compared to CC or polyphenols alone, reduction (MCF-7) and no
alteration (MDA MB-231) was observed (Fig. 4B, 5 and 6).
Interestingly, CAT expression remained unaltered throughout the
low dose exposure either separately or together versus untreated
control cells. However, activity remain unaltered at low doses with
RES alone or in sensitized cells, while CUR sensitization in CC
treated cells displayed decline in activity as compared to the CUR
alone in MCF-7 cells (Fig. 4B and 5). In MDA MB-231 cells, low
dose polyphenols down-regulated the activity of CAT which
further remained unaltered in sensitized cells as compared to
polyphenols alone and decreased vis-a `-vis CC (Fig. 4B and 6).
Further, CAT expression remains unaltered with high dose
polyphenols alone in MCF-7 and decline in MDA MB-231 cells.
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polyphenols alone, reduction and no alteration in activity was
observed (Fig. 4B, 5 and 6).
JNK and p38 Pathway Dependent Differential Expression
of Apoptotic Markers in Polyphenol Sensitized, CC
Treated MCF-7/MDA MB-231 Cells
The sequel of events regulating apoptosis vis-a `-vis oxidative
stress has JNK, p38 and p53 as key SAPKs actors [26,27]. MTT
and FACS studies in polyphenols sensitized CC treated cells
employing inhibitors (SP 600125/SB 203580/Pif) were conducted
(Fig. 7A–D).
For MTT analysis, 3–24 h exposure with CC/low dose
polyphenols slightly inhibited JNK, p38 and p53 pathway by
24 h. However with 100 mM RES and 30 mM CUR, the
significant decline of these parameters starts at 6 h until 24 h
(Fig. 7A). We therefore propose that at 6 h in MCF-7 cells, the
activation of these pathways correlates well with mitochondrial
potential supported by elevated ROS. In MDA MB-231 cells, 10
and 100 mM RES displayed no involvement of JNK and p38
pathways, while 10 and 30 mM CUR displayed their involvement
at 24 h/6 h until 24 h respectively (Fig. 7B).
Based on the above, for the flow studies on cells during 6 h
sensitization with the polyphenols, the inhibitors were individually
Figure 3. Time-dependent ROS-generation and Mitochondrial Membrane Potential (DYm). 0.2610
6 MCF-7/MDA MB-231 cells were
plated in 6-well plates, treated time-dependently (3, 6 and 24 h) with CC (10 mM) and polyphenols per se {(RES: 10/100 mM and CUR: 10/30 mM; A
(ROS-generation) and B (DYm)}; preconditioned cells with low and high dose polyphenols for 6 h and continued with CC (10 mM) for next 18 h {C
(ROS-generation) and D (DYm)}. Cells were then rinsed with PBS and then placed in a preheated 37uC fluorimeter for time-dependent measurement
of generation of H2O2 (DCFDA). DYm was determined on a Beckton–Dickinson Fluorescence Activated Cell Sorter. Flow Cytometry analysis of MCF-7
and MDA MB-231 cells stained with DCFDA was performed to confirm ROS results using N-Acetyl-l-Cysteine (L-NAC, 5 mM) 1 hr prior to treatment (E).
Data shown are the Mean 6 S.E. of one of the three similar experiments each performed in triplicate. * P,0.05; ** P,0.01; *** P,0.001, calculated
compared to control. $ P,0.05; $$ P,0.01; $$$ P,0.001 with respect to individual CC dose and # P,0.05; ## P,0.01; ### P,0.001 with respect
to individual RES dose.
doi:10.1371/journal.pone.0037736.g003
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was undertaken. Significantly reduced apoptosis through CC and
polyphenols exposure per se correlating well with MTT studies was
observed. More, in case of inhibitors (Z-VAD-FMK, SP 600125/
SB 203580/Pif) low dose polyphenols sensitized CC treated cells
registered decline in apoptosis to an extent greater than with
ligands per se in MCF-7 cells. 100 mM RES by itself significantly
decreased apoptosis with inhibitors. Notably, with 30 mM CUR
plus Z-VAD-FMK/SP 600125/Pif the magnitude of cell death
was lower unlike SB 203580 indicating the divergence of pathways
at higher molarity. Additionally, the inhibitors fail to exert any
effect at high dose of polyphenols sensitized CC treated MCF-7
cells (Fig. 7C). However, p53 null MDA MB-231 cells were
expectedly insensitive to p53 inhibitor Pif. In these cells, 10 and
100 mM RES alone as well as in sensitized cells displayed no
involvement of JNK and p38 pathways, however caspase-
mediated cell death was observed. With 10 and 30 mM CUR
alone and in sensitized cells, involvement of Caspases, JNK and
p38 pathways was noticed. In case of CC with slight inhibition of
apoptosis, other three pathways were unaffected (Fig. 7D).
In MCF-7 cells, stress activated protein kinases (SAPKs)
expression indicates pan-unaltered total JNK1/2 and p38.
Concomitantly, phosphorylation of c-Jun and ATF-2 was up-
regulated at low dose polyphenol sensitized CC treated cells versus
CC and polyphenols alone. This is supported by the data through
respective inhibitors (Fig. 5). With 100 mM RES sensitization
phospho c-jun enhanced as compared to drugs alone, while with
30 mM CUR sensitization the expression remains unaltered. The
Figure 4. Assessment of antioxidant enzymes (AOs) activity. Quantification of total GSH was accomplished using a Glutathione Assay Kit from
Sigma. 1610
8 MCF-7/MDA MB-231 cells were exposed to CC (10 mM) and polyphenols per se (RES: 10/100 mM and CUR: 10/30 mM) or sensitized with
low/high dose polyphenols for 6 h and continued with CC (10 mM) for next 18 h (A). Superoxide dismutase (SOD) and Catalase (CAT) activities were
determined according to McCord and Fridovich, and Beutler respectively. Briefly, supernatants obtained from cell extracts of untreated as well as
treated 3610
6 MCF-7/MDA MB-231 cells were analyzed for enzyme activities (B). Each data point was performed in triplicate and the results reported
as Mean Absorption 6 SE.
doi:10.1371/journal.pone.0037736.g004
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studies of MnSOD and Catalase in the presence and absence of SP
600125 and SB 203580 respectively. The inhibitors up-regulated
the expression of MnSOD and Catalase as compared to their
respective treatments (Fig. 5). SAPKs down-regulate Ser-167
phosphorylation of ER, a site that influences AF-1 ER-dependent
transcriptional activity (non-genomic events) [8,28]. With low dose
polyphenol sensitization, the Ser-167 phosphorylation decreased
as compared to polyphenols while reverse was true vis-a `-vis CC
exposure. However, on sensitization with high dose polyphenols
the combination displayed decline in Ser-167 phosphorylation vis-
a `-vis both the drugs (Fig. 8). The knowledge of stress induced Ser-
15 phosphorylation of p53-mediated apoptosis through JNK and
p38 SAPKs [2,15] made us examine the role of SP 600125 and SB
203580 respectively. Compared to untreated control, phosphor-
ylation of p53 was up-regulated dose-dependently with polyphe-
nols and CC alone suppressible by the inhibitors. At low and high
dose polyphenols sensitization in CC treated cells, phosphorylation
rises and falls respectively compared to either drug. The
phosphorylation of p53 in low dose polyphenols sensitized CC
treated cells was inhibited both by SP 600125 and SB 203580
which at higher dose remained unaltered or decreased re-
spectively. Total p53 showed constitutive expression (Fig. 5).
Phosphorylation of p53 promotes apoptosis whose downstream
effectors e.g. Bax/Bcl-2 ratio and caspase-9 [29] examined
through western analysis. CC alone and polyphenols dose-
dependently up-regulate their activation compared to untreated
control. With low dose polyphenols sensitization in CC treated
cells, the markers increased to subsequently decrease at higher
dose than either drug alone (Fig. 5).
Figure 5. JNK/p38-dependent modulation of expression of Antioxidant enzymes, p53 and apoptogenic factors in MCF-7 cells `1. For
expression analysis, 3610
6 MCF-7 cells were pre-cultured for 48 h in phenol red-free DMEM and exposed to CC (10 mM) and polyphenols per se {RES:
10/100 mM (A & B) and CUR: 10/30 mM (C & D)} or sensitized with low/high dose polyphenols for 6 h and continued with CC (10 mM) for next 18 h.
Using 10 mM of SP600125 (JNK inhibitor)/1 mM of SB 203580 (p38 inhibitor) 2 hours prior to CC exposure, 50 mg of the whole cell lysate was
separated on a 10% SDS-PAGE gel, probed with respective antisera following transfer to a nitrocellulose membrane and subsequent immunoblotting.
b-actin was used as a protein loading control. (A) RES/CC+RES without and with SP600125; (B) RES/CC+RES without and with SB203580; (C) CUR/
CC+CUR without and with SP600125; (D) CUR/CC+CUR without and with SB203580. However, for c-Jun and phospho ATF-2 detection,
immunoprecipitation and detection was carried out as detailed in Materials and Methods. Data shown is representative of one of the three similar
experiments each performed in triplicate.
doi:10.1371/journal.pone.0037736.g005
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expression where total p53, Ser-15 phosphorylation of p53 and
Bax was found to be unaltered in CC/RES/CUR exposed cells
with or without inhibitors (Fig. 6, A–D). RES dose-dependently
did not display any significant increase in the apoptosis (unaltered
Bcl-2 and Caspase-9) accompanied with no phosphorylation of c-
jun/ATF-2 (Fig. 6, A and B). On sensitization with 10 mM RES in
CC treated cells, these factors further remained unaffected with no
involvement of JNK/p38 pathway. Conversely, involvement of
JNK/p38 pathway through phosphorylation of c-Jun and ATF-2
was evidenced in100 mM RES sensitized CC treated cells versus
CC and polyphenols alone (Fig. 6, A and B). However, progressive
phosphorylation of c-jun/ATF-2, down-regulation of Bcl-2 and
unaltered Caspase-9 was observed dose-dependently in CUR
treated cells. Further, on sensitization with low dose CUR in CC
treated cells the phosphorylation of c-jun/ATF-2 further rose and
was subsequently inhibited both by SP 6000125 and SB 203580
respectively. With 30 mM CUR sensitization, phosphorylation of
c-jun/ATF-2 and Caspase-9 were down-regulated compared to
CUR alone or remained unaltered vis-a `-vis CC respectively. Total
JNK/p38 showed constitutive expression. These events were
further supported by the data through respective inhibitors.
Further, MnSOD and Catalase were also evaluated in presence of
SP 6000125 and SB 203580 whose expression remained unaltered
compared to respective treatments (Fig. 6, C and D). Finally, the
SAPKs regulated Ser-167 phosphorylation of ER alpha in MDA
MB-231 cells also displayed no change in expression in CC/RES/
CUR alone or in combination treated cells (Fig. 8).
Figure 6. JNK/p38-dependent modulation of expression of Antioxidant enzymes, p53 and apoptogenic factors in MDA MB-231
cells. For gene-product analysis, MDA MB-231 cells were pre-cultured for 48 h in phenol red-free DMEM and exposed to CC (10 mM) and polyphenols
per se {RES: 10/100 mM (A & B) and CUR: 10/30 mM (C & D)} or sensitized with low/high dose polyphenols for 6 h and continued with CC (10 mM) for
next 18 h. Using 10 mM SP600125/1 mM SB 203580, 2 hours prior to CC exposure, 50 mg of the whole cell lysate was separated on a 10% SDS-PAGE
gel, probed with respective antibodies following transfer to a nitrocellulose membrane and subsequent immunoblotting. b-actin was used as
a protein loading control. (A) RES/CC+RES without and with SP600125; (B) RES/CC+RES without and with SB203580; (C) CUR/CC+CUR without and
with SP600125; (D) CUR/CC+CUR without and with SB203580. However, for c-Jun and phospho ATF-2 detection, immunoprecipitation and detection
was carried out as detailed in Materials and Methods. Data shown is representative of one of the three similar experiments each performed in
triplicate.
doi:10.1371/journal.pone.0037736.g006
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PLoS ONE | www.plosone.org 11 June 2012 | Volume 7 | Issue 6 | e37736Figure 7. Time-dependent JNK, p38 and p53 pathway inhibition studies induced by CC and polyphenols alone and JNK/p38-
dependent apoptosis in sensitized cells. 10
4 MCF-7 (A)/MDA MB-231 (B) cells were pre-cultured for 48 h in phenol red-free DMEM then exposed
to CC (10 mM)/polyphenols per se (RES: 10/100 mM and CUR: 10/30 mM) for MTT analysis. Percentage inhibition was determined per the formula
{(Absorbance of Control – Absorbance of drug treated cells without and with inhibitor)/Absorbance of Control cells}6100. For inhibitor experiments
through Flow Cytometry, 0.2610
6 MCF-7 (C)/MDA MB-231 (D) cells were pre-cultured for 48 h in phenol red-free DMEM, exposed to CC (10 mM)/
polyphenols per se (RES: 10/100 mM and CUR: 10/30 mM) or preconditioned with low/high dose polyphenols for 6 h and continued with CC (10 mM)
for next 18 h. JNK (10 mM SP600125), p38 pathway (1 mM SB 203580), Pifithrin (15 mM Pif) and zVAD-fmk (30 mM) inhibitors were added during the
last 2 hours prior to CC exposure, followed by the analysis of the Sub-G0/G1 fraction by FACS. Each data point is the Mean 6 S.E. of one of three
similar experiments each performed in triplicate. * P,0.05, ** P,0.01, *** P,0.001 drugs compared to drug treatment without inhibitor.
doi:10.1371/journal.pone.0037736.g007
Figure 8. Ser-167 phosphorylation of AF-1 region of ER a. 3610
6 MCF-7/MDA MB-231 cells were exposed to CC (10 mM)/polyphenols per se
(RES: 10/100 mM and CUR: 10/30 mM) or sensitized with low/high dose polyphenols for 6 h and continued with CC (10 mM) for next 18 h. 50 mg of the
whole cell lysate was separated on a 10% SDS-PAGE, probed with respective antisera following transfer to a nitrocellulose membrane with
immunoblotting using b-actin as control. Data shown is one of three similar experiments each performed in triplicate.
doi:10.1371/journal.pone.0037736.g008
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Despite decades of research, the use of dietary antioxidant
supplementation during conventional chemo- and radiation
therapy remains controversial vis-a `-vis the efficacy and safety of
complementary treatment [30,31]. Several in vitro studies have
demonstrated that the concurrent administration of natural
products viz. RES [14,15,22,31], CUR [22,31–32] with chemo-
or radiation-therapy reduces treatment-related side effects with-
out/with improving the efficacy of chemotherapy. Here, we
determine the role of Centchroman (CC)/Polyphenols alone plus
polyphenols sensitized CC treated cells during stress signaling and
intracellular redox status in vitro using the established Estrogen
receptor (ER) positive (+ve) MCF-7 and negative (-ve) MDA MB-
231 Human Breast Cancer Cells (HBCCs). Polyphenols beyond
pharmacological concentrations ($10 mM) elicit ER-independent
non-genomic effects [33]. Conversely, sub-pharmacological con-
centration (#10 mM) induces sub-lethal oxidative stress through
ER-dependent non-genomic phenomena [20]. Hence, sensitizing
HBCCs with such doses may synergize/antagonize the action of
CC. On an overall basis, this may be through the increased
generation of Reactive Oxygen Species (ROS) affecting MAPK
and similar stress-signaling cascades [33–35].
The initial observation that CC significantly causes time-
dependent apoptosis (3–24 h) through oxidative stress accomplish-
ing its cytotoxicity in MCF-7/MDA MB-231 cells provided the
basis of this study (Fig. 1A and B, 2C, 3A and B). At 24 h, ROS
generation (DCFDA) and decreasing DYm triggers subsequent
events (Fig. 3A and B). Further, altered thiol, SOD/Catalase ratio
modulates redox status, induces SAPKs (JNK/p38) mediating
p53-dependent/independent apoptosis in MCF-7 (altered Bax/
Bcl-2 ratio, up-regulated caspase-9)/MDA MB-231(absence of
Bax, unaltered Bcl-2 and activated Caspase-9) (Fig. 4, 5, 6 and
7A–D). Our previous [2,3] and current study demonstrates CC
mediated up-regulation of JNK and p38 pathways (SAPK) with
greater intensity in MCF-7 than MDA MB-231. Therefore, the
ratio of MAPK/SAPK is the critical determinant of down-
regulation of Ser-167 phosphorylation, a site that influences AF-1
ER-dependent non-genomic transcriptional events in MCF-7
(Fig. 8). However, the MDA MB-231 cells are independent of
these events. We therefore, infer that the fold increase of apoptosis
was higher in MCF-7 than MDA-MB-231 cells reinforcing the
role of receptor and p53 expression [2,3].
The number of cells in sub-G0/G1 population on treatment
with low dose RES/CUR increased significantly by 6 h extending
up to 24 h in MCF-7/MDA MB-231 cells (Fig. 2A, B, D and E).
However, with RES treated MCF-7 cells, the majority was
arrested in S phase (24 h) [36] (Fig. 2A) while in CUR, the cells
continued cycling accompanied with significant apoptosis [37]
(Fig. 2D). For MDA MB-231 cells, no arrest was observed in both
the ligands (Fig. 2B and E). Unlike MDA MB-231 cells, similar
phosphorylation of Ser-167 of AF-1 region of ER alpha containing
MCF-7 cells through low dose of RES/CUR supports comparable
ER-dependent non-genomic transcriptional events compared to
control [20] (Fig. 8). Polyphenols induce ROS via SAPK (JNK and
p38 MAPK) capable of phosphorylating p53 under cell-cycle
arrest or apoptosis is well known for MCF-7 cells [21]. p53
deficient MDA MB-231 cells proceed differently which may
explain the dichotomy of apoptosis in the two cell types [2]. In
relation to this we found, low dose polyphenol at 3 and 6 h neither
showed significant ROS generation nor involvement of JNK, p38,
p53 pathways and correlates well with unaltered morphology in
MCF-7/MDA MB-231 cells (Fig. 3A and B, 5 and 6, 7A–D,
1A and B). However, at 24 h significant increase of ROS was
observed both in MCF-7/MDA-MB-231 cells. RES decreased
GSH in MCF-7 or remained unaltered in MDA MB-231 cells.
Conversely, CUR enhanced total GSH as compared to control in
both cell types as reported previously [25] (Fig. 4A). These events
were accompanied with increased MnSOD activity with un-
changed CAT in MCF-7 and decreased MnSOD, CAT in MDA
MB-231 leads to generation of ROS whose levels do not affect the
JNK/p38 signaling as well as mitochondria mediated apoptotic
events (Fig. 4, 5 and 6). We therefore, infer that polyphenols pre-
incubation sensitizes MCF-7 cells for improved CC action.
The enormity of apoptosis increased significantly in low dose
RES/CUR sensitized CC treated MCF-7/MDA MB-231 cells
with treatment time. Enhanced S phase arrest (RES sensitized)/
apoptosis (CUR sensitized) increases phosphorylation of p53 in
MCF-7 cells (Fig. 2 F and G). Simultaneously, increased JNK/p38
and decline of DYm activates downstream events such as Bax/Bcl-
2 ratio and caspase-9 (Fig. 3D, 4 and 5). ROS burst with
concomitant increase of SOD activity/unaltered CAT indicates
altered redox homeostasis in low dose polyphenol sensitized MCF-
7 cells (Fig. 3C, 4B). Increased apoptosis (RES sensitized)/G2/M
phase arrest (CUR sensitized) in the absence of phosphorylation of
p53 in MDA MB-231 cells shows the differential mode of action of
the two polyphenols. Unlike RES, CUR showed JNK/p38
mediated apoptosis in MDA MB-231 cells (Fig. 6). The foregoing
favorably contributes to the enhanced pro-apoptotic action in
CUR sensitized CC treated MDA MB-231 cells as compared to
either drug alone. We therefore, deduce that RES/CUR enhances
the CC action through ROS mediated JNK/p38 as well as
mitochondrial pathway in MCF-7 cells. However, RES/CUR
sensitization enhanced apoptosis in MDA MB-231 cells without
and with involvement of ROS mediated JNK/p38. Thus, despite
being similar, RES and CUR have subtle differences in their
molecular mode of action. The review by Howells [31] and
references therein have shown evidences for synergistic actions of
RES and CUR with various drugs in different cell lines.
RES at 100 mM caused an early (3 h)/late increase (24 h) in
ROS (Fig. 3A) reaching its nadir in MCF-7/MDA MB-231
respectively, due to accumulation of cells in G0/G1 phase (Fig. 2A
and B) [36,37]. Contrarily, with 30 mM CUR, the enhanced ROS
at 3 h was retained up to 24 h owing to cell arrest in G2/M phase
in both cell types (Fig. 3A) [38,39]. The direct relationship
between intracellular-redox cybernetics/G0/G1 and G2/M arrest
and activation of MAP kinases-mediated phosphorylative path-
ways has been demonstrated [40–42]. Here we report that,
100 mM RES/30 mM CUR preferentially causes significant
disruption of DYm (Fig. 3B), inhibition of AO enzymes expression
and induction of JNK/c-Jun and p38/p-ATF2-mediated phos-
phorylation in MCF-7 cells (Fig. 5) [21,35–37,39,41]. Unlike
100 mM RES, 30 mM CUR showed JNK/p38 mediated apoptosis
in MDA MB-231 cells (Fig. 6, 7B and D) [42,43]. Therefore, both
reduced antioxidant capacity and selective activation of different
MAP kinases act as the principal mediators of apoptosis (altered
ratio of Bax/Bcl-2 ratio and Caspase-9 activation) in MCF-7 cells
(Fig. 6) [21,36,44,45] and MDA MB-231 (decreased Bcl-2 and
activation of Caspase-9, Fig. 6) [42,43]. At the molecular level, we
conclude and others support that ER-independent non-genomic
events (down-regulation of Ser-167 phosphorylation of AF-1
region of ER) are prominent with higher dose of polyphenols in
MCF-7 [7] but not in MDA MB-231 cells (Fig. 8). The data
discussed above has been correlated with concomitant time-
dependent studies employing JNK/p38/p53 inhibitors (Fig. 7A
and B). The above events along with altered redox status sensitize
the cells for CC mediated apoptosis following 3–6 h polyphenols
treatment.
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the cells under arrest in Go/G1 (RES)/G2/M phase (CUR) as
early as 3 h in MCF-7 versus 24 h in MDA MB-231cells
preventing CC action and resultant apoptosis (Fig. 2F and G).
This thereby leaves the factors unaltered in CC treated
polyphenols sensitized cells than with polyphenols per se in both
cell types. Interestingly, CC plus RES displayed the involvement of
JNK/p38 pathways in MDA MB-231 cells (Fig. 6). This also
implies that high dose polyphenols by themselves invoke cell death.
This may be however, unachievable physiologically owing to poor
bioavailability etc. hence is more of academic value. Efforts
therefore should be directed towards modifying the structure of
polyphenols to overcome this paradox.
Therefore, low dose polyphenols sensitization with demonstrat-
ed safety vis-a `-vis normal cells can augment apoptotic efficacy of
hormonal therapeutics like CC in ER-positive/negative MCF-7/
MDA MB-231 cells. Hence, sensitization through polyphenol
under in vivo situation may improve the efficacy of hormonal-
therapy with reduced treatment-related morbidity.
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